Qube Research & Technologies LTD Bridge Bio Pharma, Inc. Transaction History

Qube Research & Technologies LTD

$91.4 Billion
Q3 2025

A detailed history of Qube Research & Technologies LTD transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 383,178 shares of BBIO stock, worth $25.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

383,178

Previous 564,216 32.09%

Holding current value

$25.4 Million

Previous $24.4 Million 18.31%

% of portfolio

0.02%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$42.78 - $54.29 $7.74 Million - $9.83 Million	-181,038 Reduced 32.09%	383,178 $19.9 Million
Q2 2025 Aug 14, 2025	SELL	$30.14 - $45.12 $5.92 Million - $8.86 Million	-196,258 Reduced 25.81%	564,216 $24.4 Million
Q1 2025 May 15, 2025	BUY	$28.12 - $37.59 $21 Million - $28.1 Million	747,707 Added 5856.56%	760,474 $26.3 Million
Q4 2024 Feb 14, 2025	BUY	$22.35 - $29.5 $285,342 - $376,626	12,767 New	12,767 $350,000
Q1 2024 May 14, 2024	BUY	$27.35 - $40.45 $63,643 - $94,127	2,327 Added 2216.19%	2,432 $75,000
Q4 2023 Feb 13, 2024	BUY	$24.02 - $43.89 $2,522 - $4,608	105 New	105 $4,000
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $3.86 Million - $5.23 Million	-290,312 Reduced 84.45%	53,473 $919,000
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $1.46 Million - $3.77 Million	203,433 Added 144.94%	343,785 $5.7 Million
Q4 2022 Feb 14, 2023	BUY	$6.74 - $11.52 $171,175 - $292,573	25,397 Added 22.09%	140,352 $1.07 Million
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $912,742 - $1.42 Million	114,955 New	114,955 $1.14 Million
Q1 2022 May 09, 2022	SELL	$7.34 - $17.16 $124,251 - $290,484	-16,928 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$11.38 - $53.41 $192,640 - $904,124	16,928 New	16,928 $282,000
Q2 2021 Aug 13, 2021	SELL	$46.47 - $63.93 $1.11 Million - $1.53 Million	-23,985 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $1.33 Million - $1.74 Million	23,985 New	23,985 $1.48 Million
Q4 2020 Feb 16, 2021	SELL	$38.38 - $71.11 $242,331 - $448,988	-6,314 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$27.2 - $42.19 $188,686 - $292,672	-6,937 Reduced 52.35%	6,314 $237,000
Q2 2020 Aug 14, 2020	BUY	$22.22 - $35.69 $294,437 - $472,928	13,251 New	13,251 $432,000

Others Institutions Holding BBIO

# of Institutions

442

Shares Held

190M

Call Options Held

11.1M

Put Options Held

1.98M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $9.84B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Bridge Bio Pharma, Inc. Transaction History